Registered Owners
- View profile →
SANBE FARMA
Kota Bandung, Jawa Barat, Indonesia
NPWP: 011049160092000
owner
Direktorat Registrasi ObatValid
CISPLATIN
- BPOM Number
- GKL1922256443A1
- Approved
- 29 March 2026
- Expiry
- 27 September 2030
- Form
- INJEKSI
About This Registration
CISPLATIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1922256443A1. Its current registration status is Valid, with the licence valid until 27 September 2030. The product is registered to SANBE FARMA and manufactured by SANBE FARMA - INDONESIA. BPOM first approved this registration in January 2026. All registration data is sourced directly from the official BPOM public database and updated daily.
Registration Details
- Application
- newaero
- Packaging
- DUS, 1 VIAL @ 50 ML
- Department
- Direktorat Registrasi Obat
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
SANBE FARMA - INDONESIA
KAB. BANDUNG BARAT
primary
Ingredients (1)
CISPLATIN
Market Intelligence
- Owner Portfolio
- SANBE FARMA holds 554 BPOM registrations
- Manufacturer Scale
- SANBE FARMA - INDONESIA produces 490 registered products
- Registration Age
- Registered for 7 months
FDA Cross-Reference
via openFDA- Generic Name
- CISPLATIN
- Product Type
- HUMAN PRESCRIPTION DRUG
- Route of Administration
- INTRAVENOUS
Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.
More products from SANBE FARMA
GEMCITABINE HYDROCHLORIDE
-GKL1522250344B1
Approved: Apr 30, 2026SERBUK INJEKSI LIOFILISASI
Products in the same class
NABOTA
-DKI2649000544B1
Approved: Mar 16, 2026SERBUK INJEKSI
DAEWOONG PHARMACEUTICAL INDONESIA - INDONESIAPROGYNOVA
-DKI2615901316A1
Approved: Mar 11, 2026TABLET SALUT GULA
MENARINI INDRIA LABORATORIES - INDONESIANUFED
-DKL2143009110A1
Approved: Mar 11, 2026TABLET
NULAB PHARMACEUTICAL INDONESIA - INDONESIACLINDAMYCIN HYDROCHLORIDE
-GKL1807122701A1
Approved: Mar 11, 2026KAPSUL
PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA